<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2314">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04412473</url>
  </required_header>
  <id_info>
    <org_study_id>7837</org_study_id>
    <nct_id>NCT04412473</nct_id>
  </id_info>
  <brief_title>COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits</brief_title>
  <acronym>CRASH</acronym>
  <official_title>COVID-19 Respiratory Distress and Antithrombotic Drugs inSubject's Habits</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current management of VID-19 consists of oxygen support without specific treatment.&#xD;
      Hospitalization may suddenly require delayed resuscitation. This evolution corresponds to an&#xD;
      atypical acute respiratory distress syndrome (ARDS), the mechanism of which is poorly&#xD;
      understood and difficult to predict. The general pathophysiology of ARDS, the vascular&#xD;
      tropism of SARS-Cov2, the description of coagulopathy and numerous pulmonary artery&#xD;
      thromboses in resuscitation and the encouraging investigation of antithrombotics in general&#xD;
      ARDS&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 30, 2020</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of Respiratory Distress and Antithrombolytic Therapy in Patients with covid19</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Sars-CoV2</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Partients hospitalised in HUS or GHRMSA for COVID-19 with diagnosis COVID-19&#xD;
        confirmed by smear or evoked by CT scan or chest X-ray without a differential diagnosis&#xD;
        retained in the medical record&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Major Subject (≥18 years)&#xD;
&#xD;
          -  Subject hospitalised in HUS or GHRMSA for COVID-19&#xD;
&#xD;
          -  The diagnosis COVID-19 confirmed by smear or evoked by CT scan or chest X-ray without&#xD;
             a differential diagnosis retained in the medical record&#xD;
&#xD;
          -  Subjects who, after being informed, do not wish to have their data reused for the&#xD;
             purposes of this research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject who expressed opposition to participating in the study&#xD;
&#xD;
          -  Subject under guardianship or trusteeship&#xD;
&#xD;
          -  Subject under safeguard of justice&#xD;
&#xD;
          -  Patient hospitalized in a geriatric service or in a ward not labeled COVID (surgery,&#xD;
             oncology,...) or in a short-term hospitalization unit without transfer to another&#xD;
             service.&#xD;
&#xD;
          -  Serious patient on admission to the emergency room and recused from resuscitation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Vincent CASTELAIN, MD, PhD</last_name>
    <phone>33 3 88 12 82 69</phone>
    <email>Vincent.CASTELAIN@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Médecine Intensive et Réanimation</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent CASTELAIN, MD, PhD</last_name>
      <phone>33 3 88 12 82 69 /</phone>
      <email>Vincent.CASTELAIN@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent CASTELAIN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stanislas DEMUTH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurine LE GOFF, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Edouard TERRADE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard GOICHOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 27, 2020</study_first_submitted>
  <study_first_submitted_qc>May 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2020</study_first_posted>
  <last_update_submitted>January 8, 2021</last_update_submitted>
  <last_update_submitted_qc>January 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sars-CoV2</keyword>
  <keyword>Covid-19</keyword>
  <keyword>Antithrombotic treatments</keyword>
  <keyword>ARDS</keyword>
  <keyword>Hypoxemia</keyword>
  <keyword>Thrombosis</keyword>
  <keyword>Pulmonary arteries</keyword>
  <keyword>Endothelial</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

